$SPRB

$43.99 -$1.16 (2.57%) Close

$SPRB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SPRB Management Team

Mr. Samir Gharib

President

Chief Financial Officer

Age 42

Compensation $929.7K USD

Sex Male

Dr. Javier Szwarcberg

Chief Executive Officer

Director

Age 55

Compensation $1.532M USD

Sex Male

Dr. Kirk Ways

Interim Chief Medical Officer

Director

Age 73

Compensation $70.97K USD

Sex Male

Mr. Michael Grey

Executive Chairman of the Board

Age 72

Compensation $89.22K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Samir Gharib President Chief Financial Officer	42	$929.7K USD	Male
Dr. Javier Szwarcberg Chief Executive Officer Director	55	$1.532M USD	Male
Dr. Kirk Ways Interim Chief Medical Officer Director	73	$70.97K USD	Male
Mr. Michael Grey Executive Chairman of the Board	72	$89.22K USD	Male

Board of Directors

From the proxy statement filed Apr 9, 2026

Directors

serving now

Independent

4 of 7

stated in the proxy

Average tenure

4.7 years

from year joined

CEO also chairs the board

Michael Grey

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Javier Szwarcberg CEO	56	2022 4 years	Not independent	None stated	None stated	Paid as CEO
Michael Grey Board chair	73	Not stated	Not independent	None stated	None stated	$79,940
Camilla V. Simpson	54	2017 9 years	Independent	None stated	GRI Bio, Inc.	Not stated
Keli Walbert	59	2025 1 year	Independent	Compensation	Apellis Pharmaceuticals, Inc.	$295,004
Kirk Ways Executive officer	74	2021 5 years	Not independent	None stated	None stated	Not stated
Percival Barretto-Ko	53	2023 3 years	Independent	Audit	None stated	$52,056
Daniel Spiegelman	67	2020 6 years	Independent	Audit · Chair	Maze Therapeutics, Inc.	$66,043

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 9, 2026

Kirk Ways, M.D., Ph.D.

a director and current Interim Chief Medical Officer

$608,313

Since January 1, 2024

Consulting agreement under which Dr. Ways provides advisory services as Interim Chief Medical Officer; company paid him for services.

With the Company Open in proxy

Comments

Company Executives

$SPRB Management Team

Mr. Samir Gharib

Dr. Javier Szwarcberg

Dr. Kirk Ways

Mr. Michael Grey

Board of Directors

Related-party transactions